Cleared Traditional

K191388 - FloPatch (FP110)

K191388 is the FDA 510(k) clearance for FloPatch (FP110) by Flosonics Medical (R/A 1929803 Ontario Corp.). It is a Class 2 Cardiovascular device (product code DPW) cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K191388 · Flosonics Medical (R/A 1929803 Ontario Corp.) · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2019
Decision
28d
Days
Class 2
Risk

K191388 is an FDA 510(k) clearance for the FloPatch (FP110). Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Flosonics Medical (R/A 1929803 Ontario Corp.) (Sudbury, CA). The FDA issued a Cleared decision on June 21, 2019 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Flosonics Medical (R/A 1929803 Ontario Corp.) devices

Submission Details

510(k) Number K191388 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2019
Decision Date June 21, 2019
Days to Decision 28 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 125d · This submission: 28d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

Device Classification

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
Mark Job

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 33
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K191388.
FloPatch (FP120)
K200337 · Flosonics Medical (R/A 1929803 Ontario Corp.) · Mar 2020
FlowMet
K192966 · Laser Associated Sciences, Inc. · Jan 2020
SRX Handheld Doppler, DMX Handheld Doppler, Obstetric Probes, Vascular Probes
K183574 · Huntleigh Healthcare , Ltd. · Sep 2019
FlowMet-R
K182494 · Laser Associated Sciences, Inc. · Feb 2019
iCertainty
K181269 · Rfpi · Dec 2018
Deltex Medical CardioQ-EDM+, Deltex Medical CardioQ-EDM
K172457 · Deltex Medical Limited · Jun 2018